Mexican authorities said they are investigating the case of a 32-year-old health worker who was hospitalized with suspected encephalomyelitis after receiving the Pfizer-BioNTech coronavirus vaccine.
The doctor, who has not been named, was admitted to the intensive care unit of a state hospital after she developed convulsions, difficulty breathing and rashes.
The Mexican Ministry of Health said that the preliminary diagnosis was encephalomyelitis (inflammation of the brain and spinal cord).
The department added that the patient was prone to allergic reactions, and during clinical trials there was no evidence that any of the subjects developed brain inflammation after the vaccine was administered.
Reporters were unable to contact Pfizer and BioNTech for comment on this incident.
Earlier, the Agency for Safety and Development in the field of pharmaceuticals, Fimea (Finland) received the first application in the country about an adverse reaction to the coronavirus vaccine. In Finland, vaccination with Pfizer-BioNTech started on December 27, 2020.
© Times of U